Drug intelligence / Profile preview

triamcinolone acetonide + ropivacaine

Development stage: Unknown
Lead developer: Apothecon
Modality: Small Molecules
Administration: Injection, Perineural, Intraarticular

Overview

Triamcinolone acetonide + ropivacaine is a combination medication that pairs a corticosteroid (triamcinolone acetonide) with a local anesthetic (ropivacaine). This combination leverages the anti-inflammatory properties of triamcinolone with the nerve-blocking capabilities of ropivacaine. The combination has been studied for various applications in pain management, particularly: - Continuous nerve blocks after lung cancer treatment - Postoperative pain management in major spinal surgery - Joint and soft tissue injections Different dosage combinations have been researched, including 10mg+10mg, 25mg+25mg, and 50mg+50mg formulations.

Brand names: Kenalog
Other names: Kenalog + RopivacaineTriamcinolone acetonide + Ropivacaine hydrochloride

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on triamcinolone acetonide + ropivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on triamcinolone acetonide + ropivacaine.

Explore the full profile